Meta Biomed Co., Ltd. (KOSDAQ:059210)

Meta Biomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 27, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	101,776	99,718	52,832	66,184	64,352	64,799
Market Cap Growth	-2.90%	88.74%	-20.17%	2.85%	-0.69%	-6.02%
Enterprise Value	106,372	130,453	76,546	89,589	96,285	96,073
Last Close Price	4450.00	4324.16	2280.03	2828.33	2729.28	2695.07
PE Ratio	4.54	9.89	20.11	6.95	-	19.36
PS Ratio	0.95	1.20	0.77	1.13	1.43	1.09
PB Ratio	1.09	1.37	0.83	1.10	1.30	1.18
P/TBV Ratio	1.08	1.46	0.91	1.16	1.38	1.25
P/FCF Ratio	8.68	-	-	7.30	24.43	-
P/OCF Ratio	4.91	9.76	5.77	5.94	13.24	22.62
EV/Sales Ratio	1.13	1.57	1.11	1.52	2.14	1.62
EV/EBITDA Ratio	4.79	8.80	8.30	10.14	14.92	10.15
EV/EBIT Ratio	6.18	12.30	14.27	17.03	38.30	16.70
EV/FCF Ratio	9.08	-	-	9.88	36.55	-
Debt / Equity Ratio	0.67	0.61	0.70	0.57	1.01	0.70
Debt / EBITDA Ratio	3.45	3.00	4.78	3.90	7.73	4.06
Debt / FCF Ratio	9.50	-	-	3.80	18.95	-
Asset Turnover	0.62	0.66	0.62	0.56	0.43	0.59
Inventory Turnover	3.30	2.99	2.65	2.10	1.58	2.35
Quick Ratio	0.87	0.71	0.75	0.76	0.70	0.61
Current Ratio	1.18	1.12	1.14	1.20	1.10	1.04
Return on Equity (ROE)	19.14%	14.74%	4.61%	17.37%	-5.92%	10.84%
Return on Assets (ROA)	4.99%	5.28%	2.99%	3.12%	1.49%	3.58%
Return on Capital (ROIC)	5.75%	5.90%	3.32%	3.39%	1.63%	3.97%
Return on Capital Employed (ROCE)	12.30%	12.40%	7.00%	8.10%	4.20%	9.00%
Earnings Yield	22.01%	10.11%	4.97%	14.39%	-6.36%	5.16%
FCF Yield	11.51%	-1.27%	-11.80%	13.70%	4.09%	-7.25%
Dividend Yield	0.44%	0.46%	0.88%	0.71%	0.37%	0.37%
Payout Ratio	2.04%	4.54%	17.43%	2.40%	-	6.97%
Buyback Yield / Dilution	-56.31%	0.06%	0.07%	0.61%	1.08%	0.68%
Total Shareholder Return	-55.87%	0.53%	0.95%	1.31%	1.44%	1.05%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.